Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Non-Current Assets (2009 - 2026)

Updated

Regeneron Pharmaceuticals (REGN) posted Non-Current Assets of $23.28 billion for Q2 2026, up 9.0% from $21.36 billion a year earlier and up 2.8% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Regeneron Pharmaceuticals' Non-Current Assets came in at $22.54 billion, up 18.0% from FY2024.

  • Annual Non-Current Assets has increased for 14 consecutive years, with a five-year compound annual growth rate of 25.0% (FY2020 to FY2025).
  • In prior years, Regeneron Pharmaceuticals' Non-Current Assets was $19.1 billion in FY2024 (+40.4%), $13.6 billion in FY2023 (+2.0%), $13.33 billion in FY2022 (+16.7%) and $11.42 billion in FY2021 (+54.7%).
  • The Q2 2026 figure stands as the highest quarterly Non-Current Assets in data going back to Q4 2009.
  • On a year-over-year basis, Non-Current Assets has increased in each of the last 57 quarters, with growth averaging 24.0% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Non-Current Assets ranged from 2.0% (Q4 2023) to 56.1% (Q1 2022).
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $22.66 billion (Q1 2026), $22.54 billion (Q4 2025) and $22.19 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 141.29 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 101.45 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 87.87 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 35.42 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 159.77 Bn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 23.28 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.28 Bn
Mar 31, 2026 22.66 Bn
Dec 31, 2025 22.54 Bn
Sep 30, 2025 22.19 Bn
Jun 30, 2025 21.36 Bn
Mar 31, 2025 19.97 Bn
Dec 31, 2024 19.10 Bn
Sep 30, 2024 18.11 Bn
Jun 30, 2024 17.01 Bn
Mar 31, 2024 15.50 Bn
Dec 31, 2023 13.60 Bn
Sep 30, 2023 13.53 Bn
Jun 30, 2023 13.73 Bn
Mar 31, 2023 13.15 Bn
Dec 31, 2022 13.33 Bn
Sep 30, 2022 12.25 Bn
Jun 30, 2022 11.68 Bn
Mar 31, 2022 12.04 Bn
Dec 31, 2021 11.42 Bn
Sep 30, 2021 9.90 Bn
API Access

Regeneron Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=REGN&period=max&api_key=YOUR_API_KEY